Prostate Cancer Vaccine Enhanced
While widely researched, highly sought after and well-funded, vaccines for most cancers aren't easy to implement. Since a vaccine trains the immune system to attack foreign cells, and cancer cells are still human, the level of precision is difficult.
Medicare to Pay for Prostate Cancer Drug
Medicare has announced it will pay for Provenge ( sipuleucel-T ) to treat metastatic prostate cancer. This drug extends the life of patients by about four months.